Status:
UNKNOWN
Local Steroid Treatment for Idiopathic Granulomatous Mastitis (LSTIGM)
Lead Sponsor:
Peking Union Medical College Hospital
Conditions:
Granulomatous Mastitis
Eligibility:
FEMALE
18-60 years
Phase:
PHASE4
Brief Summary
This study evaluates the clinical response rate of local steroids in the treatment of idiopathic granulomatous mastitis in female adults. Half of the participants will receive local injection combined...
Detailed Description
Idiopathic granulomatous mastitis (IGM) is a rare benign inflammatory breast disease of unknown etiology.Clinical presentation of IGM can be variable. Some findings may be confused with breast maligna...
Eligibility Criteria
Inclusion
- Idiopathic Granulomatous Mastitis
- Require non-surgical treatment
Exclusion
- Breast Carcinoma
Key Trial Info
Start Date :
February 19 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03766997
Start Date
February 19 2019
End Date
January 1 2022
Last Update
December 3 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Breast Surgery,Peking Union Medical College Hospital
Beijing, Beijing Municipality, China, 100730